Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma

BACKGROUND: Disruptor of telomeric silencing 1-like (Dot1l), a histone methyltransferase that targets the histone H3 lysine 79 (H3K79), has been reported that its high expression is associated with various cancers, while the association between Dot1l expression and clear-cell renal cell carcinoma (c...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yang, Liu, Li, Wang, Jiajun, Xi, Wei, Xia, Yu, Bai, Qi, Xiong, Ying, Long, Qilai, Xu, Jiejie, Guo, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356697/
https://www.ncbi.nlm.nih.gov/pubmed/27713173
http://dx.doi.org/10.18632/oncotarget.12476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356697/
https://www.ncbi.nlm.nih.gov/pubmed/27713173
http://dx.doi.org/10.18632/oncotarget.12476

Ejemplares similares